Patent term restoration has been adopted by several jurisdictions, with varying success. Mexico faces several issues with sanitary authorisations and patent examination, so patent term restoration would be a viable remedy for patent holders. The TPP might enable this.
The Trans-Pacific Partnership (TPP) is a free trade agreement (FTA) which aims to liberalise commerce between economies of the Asia-Pacific region. Chile, New Zealand, Singapore and Brunei are members of the agreement, while the US, Australia, Vietnam, Peru, Malaysia, Canada and Mexico are negotiating partners. Japan has officially announced its intention to join the treaty, while Taiwan, the Philippines, Laos, Colombia and Thailand have also expressed their interest.
The TPP has stirred controversy and protests due to the contents of several leaked documents regarding its provisions, particularly regarding intellectual property and copyright. The allegedly secrecy of negotiations and the lack of transparency are also hotly debated topics among its detractors.
The treaty has been considered as a way to counter China’s economic and political influence in the region, but the multiple groups opposing it generally overlook this and other arguments, focusing instead on its copyright provisions, voicing concerns regarding freedom of speech on the Internet and access to culture.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
TPP, patent term restoration, pharmaceuticals, Mexico